Company intelligence / Profile preview

Consilx

Singapore

Ownership: Private
Development stage: Other

Overview

Consilx provides digital and blockchain-based technology platforms to enable patient engagement, eConsent, direct data collection, decentralized trials, and digital transformation in clinical trials. Its 'LifeLedger' platform uses blockchain for secure, compliant data/document management, user identity, and end-to-end trial process transparency. The company does not develop therapeutics or devices itself; it enables clinical research digitally.[1][2][3][5][6][9]

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Global Top 10 IT & Product Services CompanyUS Healthcare Management Company

Beyond the preview

Go deeper on Consilx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Consilx.

Explore the full profile